// App-Quantinova.ai

1539 : Live circulating tumor cells as a predictive biomarker of response to neoadjuvant chemoradiotherapy for resectable pancreatic cancer

Researchers

Presenter

  • Masahiro Tanemura

Principal Investigators

  • Kenta Furukawa

  • Masaki Wakasugi

  • Kentaro Kishi

  • Yasuo Urata

  • Kiyomi Taniyama

  • Hiroki Akamatsu

Medical Centers

  • Department of Surgery, Osaka Rosai Hospital, Sakai, Japan

  • Oncolys BioPharma, Inc., Japan.

  • Department of Pathology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.

Locations

  • Japan

Companies

  • Oncolys BioPharma In

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • Carbohydrate antigen 19-9

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved